Chief Scientific Officer
Wed, Aug 12, 2026
8d ago
43 shares @ $35.00
Decreased holdings by -0.10%
Net across this filing: 0.00% (+0 shares)
12th largest trade (out of 29)
Planned (10b5-1)
“This exercise and subsequent sale was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2025.”Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Net holdings across this filing: +0.0% (+0 shares)
Price 42% above 200-day moving average
Small Cap stock — insider trades carry more weight